Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 4 2Phase 2/3 2Phase NA 1Phase EARLY_PHASE1 1

Status

Terminated 2Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1

Conditions

Neoplasms 3Colonic Neoplasms 3Breast Neoplasms 3Pain 2Leiomyoma 2Wounds and Injuries 1Stomatitis 1Postoperative Hemorrhage 1Mucositis 1Malignant Pleural Neoplasm 1Inflammatory Bowel Diseases 1Ileus 1Head and Neck Neoplasms 1Feeding and Eating Disorders 1Diverticulitis 1Colorectal Neoplasms 1Cancer Pain 1Agnosia 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Lidocaine × Clear all
NCT04250805 2024-01-31

GASTROXY

Centre Hospitalier Universitaire de Saint Etienne

Phase 2 Terminated
17 enrolled

Feeding and Eating Disorders, Neoplasms, Pain

NCT02606994 2019-02-06

TPvsM

Oral Defense, LLC

Phase 2 Terminated
1 enrolled
Other

Neoplasms, Stomatitis, Mucositis

NCT00321347 2012-06-22

Intravenous (IV) Lidocaine for Opioid-refractory Pain

San Diego Hospice & Palliative Care

Phase 2 Withdrawn

Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡